Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicholas B. Larson, PhD"'
Autor:
Sheila M. Manemann, MPH, Susan A. Weston, MS, Ruoxiang Jiang, BSc, Nicholas B. Larson, PhD, Véronique L. Roger, MD, MPH, Paul Y. Takahashi, MD, MPH, Alanna M. Chamberlain, PhD, Mandeep Singh, MD, Jennifer L. St. Sauver, PhD, Suzette J. Bielinski, PhD, MEd
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 7, Iss 3, Pp 194-202 (2023)
Objective: To compare the 1-year health care utilization and mortality in persons living with heart failure (HF) before and during the coronavirus disease 2019 (COVID-19) pandemic. Patients and Methods: Residents of a 9-county area in southeastern Mi
Externí odkaz:
https://doaj.org/article/8d8e32f845934bdab759fe00e6743066
Autor:
Richard A. Ferraro, MD, Oluseye Ogunmoroti, MD, MPH, Di Zhao, PhD, Chiadi E. Ndumele, MD, PhD, Joao A.C. Lima, MD, Vinithra Varadarajan, MBBS, Vinita Subramanya, MBBS, MPH, Ambarish Pandey, MD, Nicholas B. Larson, PhD, Suzette J. Bielinski, PhD, Erin D. Michos, MD, MHS
Publikováno v:
CJC Open, Vol 5, Iss 5, Pp 364-372 (2023)
Background: Hepatocyte growth factor (HGF) is a cytokine linked to incident heart failure (HF), particularly HF with preserved ejection fraction (HFpEF). Increases in left ventricular (LV) mass and concentric remodelling defined by increasing mass-to
Externí odkaz:
https://doaj.org/article/6ae364f082a54e9e8aefc1a3761efbaf
Autor:
Guilherme S. Lopes, PhD, Sheila M. Manemann, MPH, Susan A. Weston, MS, Ruoxiang Jiang, BSc, Nicholas B. Larson, PhD, Ethan D. Moser, BS, Véronique L. Roger, MD, MPH, Paul Y. Takahashi, MD, Yader Sandoval, MD, Malcolm R. Bell, MD, Alanna M. Chamberlain, PhD, LaPrincess C. Brewer, MD, MPH, Mandeep Singh, MD, Jennifer L. St. Sauver, PhD, Suzette J. Bielinski, PhD, MEd
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 1, Pp 77-85 (2022)
Objective: To study associations between the Minnesota coronavirus disease 2019 (COVID-19) mitigation strategies on incidence rates of acute myocardial infarction (MI) or revascularization among residents of Southeast Minnesota. Methods: Using the Ro
Externí odkaz:
https://doaj.org/article/78952ec9217b4269b849119a45ee863f
Autor:
Ye Zhu, MD, PhD, Guilherme S. Lopes, PhD, Suzette J. Bielinski, PhD, MEd, Bijan J. Borah, PhD, Nicholas B. Larson, PhD, MS, Ann M. Moyer, MD, PhD, Janet E. Olson, PhD, Liewei Wang, MD, PhD, Richard Weinshilboum, MD, Jennifer L. St. Sauver, PhD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 1, Pp 35-45 (2021)
Objective: To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated with treatment problems, and the willingness to pay to avoid tr
Externí odkaz:
https://doaj.org/article/40c3c9a4b38b4c6ea5cf5d661362b182